CME Group Inc. $CME Shares Purchased by Canada Post Corp Registered Pension Plan

Canada Post Corp Registered Pension Plan boosted its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 16.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,447 shares of the financial services provider’s stock after purchasing an additional 3,832 shares during the period. Canada Post Corp Registered Pension Plan’s holdings in CME Group were worth $7,495,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Stephens Investment Management Group LLC acquired a new stake in CME Group in the fourth quarter valued at approximately $224,000. Stephens Inc. AR grew its position in CME Group by 48.6% in the fourth quarter. Stephens Inc. AR now owns 3,653 shares of the financial services provider’s stock valued at $998,000 after acquiring an additional 1,194 shares in the last quarter. AlphaCore Capital LLC grew its position in CME Group by 212.9% in the fourth quarter. AlphaCore Capital LLC now owns 2,522 shares of the financial services provider’s stock valued at $689,000 after acquiring an additional 1,716 shares in the last quarter. DNB Asset Management AS grew its position in CME Group by 45.2% in the fourth quarter. DNB Asset Management AS now owns 110,256 shares of the financial services provider’s stock valued at $30,109,000 after acquiring an additional 34,298 shares in the last quarter. Finally, Lockheed Martin Investment Management Co. grew its position in CME Group by 12.0% in the fourth quarter. Lockheed Martin Investment Management Co. now owns 59,330 shares of the financial services provider’s stock valued at $16,202,000 after acquiring an additional 6,340 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Up 0.4%

NASDAQ:CME opened at $298.86 on Friday. The company has a market capitalization of $108.29 billion, a price-to-earnings ratio of 25.50, a price-to-earnings-growth ratio of 3.61 and a beta of 0.23. CME Group Inc. has a one year low of $257.17 and a one year high of $329.16. The stock has a 50-day simple moving average of $298.07 and a 200 day simple moving average of $288.06. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same period last year, the firm earned $2.80 earnings per share. Sell-side analysts predict that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s payout ratio is currently 44.37%.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

Insiders Place Their Bets

In other CME Group news, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction on Friday, February 20th. The shares were sold at an average price of $305.90, for a total value of $91,770.00. Following the completion of the transaction, the director owned 24,999 shares of the company’s stock, valued at $7,647,194.10. The trade was a 1.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the transaction, the general counsel directly owned 7,192 shares of the company’s stock, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 7,791 shares of company stock valued at $2,489,421 over the last 90 days. 0.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CME has been the subject of several recent research reports. Royal Bank Of Canada increased their price objective on shares of CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research report on Thursday, February 5th. UBS Group reaffirmed a “neutral” rating and issued a $310.00 price objective on shares of CME Group in a research report on Friday, February 6th. Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, April 26th. Keefe, Bruyette & Woods started coverage on CME Group in a research note on Wednesday, April 8th. They set a “market perform” rating and a $305.00 target price for the company. Finally, Raymond James Financial raised their target price on CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research note on Monday, April 6th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $305.29.

Check Out Our Latest Stock Analysis on CME Group

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.